arginine vasopressin has been researched along with Shock, Cardiogenic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Albuisson, E; Grandmougin, D; Klein, T; Levy, B; Liu, Y; Orlowski, S; Tran, N | 1 |
| Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Torgersen, C; Wenzel, V | 1 |
| Morgenthaler, NG | 1 |
| Gortner, L; Gottschling, S; McGuire, W; Meyer, S; Mohammed Shamdeen, G | 1 |
| Dünser, MW; Hasibeder, WR; Meier-Hellmann, A; Wenzel, V | 1 |
| Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Wenzel, V | 1 |
| Gregg, D; Helman, DN; Landry, DW; Morales, DL; Naka, Y; Oz, MC; Williams, MR | 1 |
| Boros, M; Kaszaki, J; Laczi, F; Nagy, S; Tárnoky, K; Vecsernyés, M | 1 |
3 review(s) available for arginine vasopressin and Shock, Cardiogenic
| Article | Year |
|---|---|
Copeptin: a biomarker of cardiovascular and renal function.
Topics: Arginine Vasopressin; Biomarkers; Blood Volume; Cardiovascular Diseases; Cardiovascular System; Glycopeptides; Heart Failure; Humans; Kidney; Kidney Diseases; Myocardial Infarction; Prognosis; ROC Curve; Shock, Cardiogenic; Stroke; Vasopressins | 2010 |
The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.
Topics: Adolescent; Arginine Vasopressin; Cardiac Output, Low; Cardiopulmonary Resuscitation; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Heart Arrest; Hemodynamics; Hospital Mortality; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lypressin; Male; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Shock, Septic; Survival Rate; Terlipressin; Young Adult | 2011 |
[Arginine-vasopressin in septic and vasodilatorial shock].
Topics: Arginine Vasopressin; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2006 |
5 other study(ies) available for arginine vasopressin and Shock, Cardiogenic
| Article | Year |
|---|---|
Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Extracorporeal Membrane Oxygenation; Heart Arrest; Male; Norepinephrine; Resuscitation; Shock, Cardiogenic; Swine; Vasoconstrictor Agents | 2021 |
[Advanced vasodilatory shock. One-year survival after arginine vasopressin therapy].
Topics: Aged; Arginine Vasopressin; Cause of Death; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Shock, Cardiogenic; Shock, Septic; Survival Analysis; Systemic Inflammatory Response Syndrome; Vasodilation | 2009 |
[Vasopressin as a rescue vasopressor agent. Treatment of selected cardiogenic shock states].
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Blood Pressure; Critical Illness; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pulmonary Wedge Pressure; Sepsis; Shock, Cardiogenic; Treatment Outcome; Vasoconstrictor Agents | 2007 |
Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock.
Topics: Arginine Vasopressin; Blood Pressure; Cardiac Output; Female; Follow-Up Studies; Heart-Assist Devices; Humans; Hypotension; Incidence; Male; Middle Aged; Norepinephrine; Retrospective Studies; Risk Assessment; Safety; Shock, Cardiogenic; Vascular Resistance; Vasoconstrictor Agents; Vasodilation; Vasomotor System | 2000 |
Humoral changes in shock induced by cardiac tamponade.
Topics: Animals; Arginine Vasopressin; Cardiac Tamponade; Dogs; Epinephrine; Female; Hemodynamics; Histamine; Male; Norepinephrine; Renin; Shock, Cardiogenic; Thromboxane B2; Vasoconstriction | 1989 |